Revolutionizing drug discovery: an AI-powered transformation of molecular docking

Fadahunsi, Adeola Abraham; Uzoeto, Henrietta Onyinye; Okoro, Nkwachukwu Oziamara; Cosmas, Samuel; Durojaye, Olanrewaju Ayodeji; Odiba, Arome Solomon

doi:10.1007/s00044-024-03253-9

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Book1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 110 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Discovery of pyrazolo[1,5-a]pyrimidine derivatives targeting TLR4−TLR4∗ homodimerization via AI-powered next-generation screening

Jiang,

Yan,

Zhang

et al. 2024

European Journal of Medicinal Chemistry

View full text Add to dashboard Cite

Discovery of pyrazolo[1,5-a]pyrimidine derivatives targeting TLR4−TLR4∗ homodimerization via AI-powered next-generation screening

Jiang,

Yan,

Zhang

et al. 2024

European Journal of Medicinal Chemistry

View full text Add to dashboard Cite

Study on AI-Powered Advanced Drug Discovery for Enhancing Privacy and Innovation in Healthcare

Arunachalam,

Usharani,

Thirumal

et al. 2024

Advances in Medical Technologies and Clinical Practice

View full text Add to dashboard Cite

The chapter discusses the integration of artificial intelligence (AI) in healthcare, highlighting its potential in drug discovery and development. It emphasizes AI-driven methodologies for target identification, compound screening, and lead optimization, while ensuring data security and compliance with privacy regulations. It explores the use of machine learning algorithms like deep learning and reinforcement learning for predicting drug efficacy, safety profiles, and personalized treatment, while also discussing the ethical challenges of utilizing vast datasets and the importance of anonymization techniques. The chapter explores the use of AI in drug discovery, highlighting its impact on time and cost reduction. It suggests that by balancing innovation with strict privacy measures, AI can improve patient outcomes and streamline drug development processes. It provides insights into current trends and future directions.

show abstract

Revolutionizing drug discovery: an AI-powered transformation of molecular docking

Cited by 2 publications

References 110 publications

Discovery of pyrazolo[1,5-a]pyrimidine derivatives targeting TLR4−TLR4∗ homodimerization via AI-powered next-generation screening

Discovery of pyrazolo[1,5-a]pyrimidine derivatives targeting TLR4−TLR4∗ homodimerization via AI-powered next-generation screening

Study on AI-Powered Advanced Drug Discovery for Enhancing Privacy and Innovation in Healthcare

Contact Info

Product

Resources

About